References
- World Health Organization. WHO expert consultation on rabies. TRS 982. WHO, Geneva 2013.
- Lang J, Duong GH, Nguyen VG, Le TT, Nguyen CV, Kesmedjian V, Plotkin SA. Randomised feasibility trial of pre-exposure rabies vaccination with DTP-IPV in infants. Lancet 1997; 349:1663 - 5; http://dx.doi.org/10.1016/S0140-6736(96)10085-4; PMID: 9186385
- Shanbag P, Shah N, Kulkarni M, Juvekar M, Madhusudana SN, Vakil HB, Malerczyk C. Protecting Indian schoolchildren against rabies: pre-exposure vaccination with purified chick embryo cell vaccine (PCECV) or purified verocell rabies vaccine (PVRV). Hum Vaccin 2008; 4:365 - 9; http://dx.doi.org/10.4161/hv.4.5.5987; PMID: 18398307
- Kamoltham T, Thinyounyong W, Phongchamnaphai P, Phraisuwan P, Khawplod P, Banzhoff A, et al. Preexposure rabies vaccination of children in Thailand using Purified Chick Embryo Cell Rabies Vaccine intra dermally is immunogenic and safe. J Pedod 2007; 151:173 - 7; http://dx.doi.org/10.1016/j.jpeds.2007.02.044
- A clinical evaluation of safety and immunogenicity of purified chick embryo cell rabies vaccine (Vaxirab N) administered intradermally as pre exposure prophylaxis in healthy volunteers. 2010, India.
- A clinical evaluation of safety and immunogenicity of purified chick embryo cell rabies vaccine (Vaxirab N) administered intramuscularly as post exposure prophylaxis in animal bite cases. 2011, India.
- A clinical evaluation of safety and immunogenicity of purified chick embryo cell rabies vaccine (Vaxirab N) administered intradermally as post exposure prophylaxis in animal bite cases. 2011,India.
- World Health OrganizationVaccine safety basics post-licensure vaccine safety. [Internet]. Geneva: WHO Press; Available from: http://www.who.int/vaccine_safety/initiative/tech_support/Vaccine-safety-E-course-manual.pdf